文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

静脉注射后金纳米颗粒的粒径依赖性器官分布。

Particle size-dependent organ distribution of gold nanoparticles after intravenous administration.

作者信息

De Jong Wim H, Hagens Werner I, Krystek Petra, Burger Marina C, Sips Adriënne J A M, Geertsma Robert E

机构信息

Laboratory for Health Protection Research, National Institute for Public Health and the Environment (RIVM), Antonie van Leeuwenhoeklaan 9, Bilthoven, The Netherlands.

出版信息

Biomaterials. 2008 Apr;29(12):1912-9. doi: 10.1016/j.biomaterials.2007.12.037. Epub 2008 Feb 1.


DOI:10.1016/j.biomaterials.2007.12.037
PMID:18242692
Abstract

A kinetic study was performed to determine the influence of particle size on the in vivo tissue distribution of spherical-shaped gold nanoparticles in the rat. Gold nanoparticles were chosen as model substances as they are used in several medical applications. In addition, the detection of the presence of gold is feasible with no background levels in the body in the normal situation. Rats were intravenously injected in the tail vein with gold nanoparticles with a diameter of 10, 50, 100 and 250 nm, respectively. After 24 h, the rats were sacrificed and blood and various organs were collected for gold determination. The presence of gold was measured quantitatively with inductively coupled plasma mass spectrometry (ICP-MS). For all gold nanoparticle sizes the majority of the gold was demonstrated to be present in liver and spleen. A clear difference was observed between the distribution of the 10 nm particles and the larger particles. The 10 nm particles were present in various organ systems including blood, liver, spleen, kidney, testis, thymus, heart, lung and brain, whereas the larger particles were only detected in blood, liver and spleen. The results demonstrate that tissue distribution of gold nanoparticles is size-dependent with the smallest 10nm nanoparticles showing the most widespread organ distribution.

摘要

进行了一项动力学研究,以确定粒径对大鼠体内球形金纳米颗粒组织分布的影响。金纳米颗粒被选作模型物质,因为它们在多种医学应用中被使用。此外,在正常情况下,体内不存在金的背景水平,因此检测金的存在是可行的。分别给大鼠尾静脉注射直径为10、50、100和250纳米的金纳米颗粒。24小时后,处死大鼠并收集血液和各种器官用于金的测定。用感应耦合等离子体质谱法(ICP-MS)对金的存在进行定量测量。对于所有粒径的金纳米颗粒,大部分金都存在于肝脏和脾脏中。观察到10纳米颗粒与较大颗粒的分布存在明显差异。10纳米颗粒存在于包括血液、肝脏、脾脏、肾脏、睾丸、胸腺、心脏、肺和脑在内的各种器官系统中,而较大颗粒仅在血液、肝脏和脾脏中被检测到。结果表明,金纳米颗粒的组织分布取决于粒径,最小的10纳米纳米颗粒显示出最广泛的器官分布。

相似文献

[1]
Particle size-dependent organ distribution of gold nanoparticles after intravenous administration.

Biomaterials. 2008-4

[2]
Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size.

Colloids Surf B Biointerfaces. 2008-10-15

[3]
The kinetics of the tissue distribution of silver nanoparticles of different sizes.

Biomaterials. 2010-8-4

[4]
Tissue distribution and toxicity of intravenously administered titanium dioxide nanoparticles in rats.

Arch Toxicol. 2008-3

[5]
Intravenously administered gold nanoparticles pass through the blood-retinal barrier depending on the particle size, and induce no retinal toxicity.

Nanotechnology. 2009-11-19

[6]
In vitro permeation of gold nanoparticles through rat skin and rat intestine: effect of particle size.

Colloids Surf B Biointerfaces. 2008-8-1

[7]
Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice.

Biochem Biophys Res Commun. 2010-2-12

[8]
Protracted elimination of gold nanoparticles from mouse liver.

Nanomedicine. 2009-6

[9]
Effect of surface coating on the biodistribution profile of gold nanoparticles in the rat.

Eur J Pharm Biopharm. 2011-9-16

[10]
Comparison of gene expression profiles in mice liver following intravenous injection of 4 and 100 nm-sized PEG-coated gold nanoparticles.

Toxicol Lett. 2009-12-1

引用本文的文献

[1]
From Past to Present: Gold Nanoparticles (AuNPs) in Daily LifeSynthesis Mechanisms, Influencing Factors, Characterization, Toxicity, and Emerging Applications in Biomedicine, Nanoelectronics, and Materials Science.

ACS Omega. 2025-7-30

[2]
Decoration of gold nanoparticles with glycopeptides leads to a lower cellular uptake and liver retention.

Nanoscale Adv. 2025-8-12

[3]
Immunomodulatory Effects of Gold Nanoparticles: Impacts on Immune Cells and Mechanisms of Action.

Nanomaterials (Basel). 2025-8-6

[4]
Nanomedicine for Diagnosis and Treatment of Cardiac Fibrosis.

Int J Nanomedicine. 2025-8-7

[5]
Multiphoton Luminescence Imaging: A Label-Free Tool for Visualizing the Long-Term Fate of Gold Nanoparticles in Tissue.

ACS Nano. 2025-8-19

[6]
From conventional therapy to novel nano-based approaches. A focus on prostate cancer.

Nanomedicine (Lond). 2025-6

[7]
Liquid chromatography-based metallomics and transmission electron microscopy reveal gold nanoparticle surface treatment with vicinal dithiols to abolish protein corona formation.

Nanomedicine (Lond). 2025-5

[8]
Bright Semiconductor Quantum Dots Shed New Light on Precision Nanomedicine for Various Diseases.

Small Sci. 2023-11-27

[9]
Nanotechnology to Overcome Blood-Brain Barrier Permeability and Damage in Neurodegenerative Diseases.

Pharmaceutics. 2025-2-20

[10]
Innate immunity-modulating nanobiomaterials for controlling inflammation resolution.

Matter. 2024-11-6

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索